Search results for: 'driving organization growth through ai'

AI technologies and platforms are entering a new stage of maturity. Most organizations now have access to capable models and have run pilots across multiple functions. The real question is no longer whether AI works, but where it can create sustained growth and how it can be scaled without introducing cost volatility, operational risk, or governanc...

09 Sep 2024  |  Global  |  Technology Research

AI-based Drug Repurposing Market, Growth Opportunities, Global, 2024-2029

AI-based Drug Repurposing is emerging as a new and faster approach to bringing drugs to patients.

Infographics

×

This study analyzes the emergence of AI-based drug repurposing and examines the factors driving and hindering adoption. The limitation of traditional drug discovery has led to the growing interest in AI -based drug repurposing, which offers numerous advantages in terms of time, speed, and cost. AI-based drug repurposing has been explored across dif...

AI-enhanced formulation transforms how advanced materials are designed, optimized, and commercialized, shifting from empirical experimentation to predictive, data-driven discovery. By combining AI, ML, and materials informatics, formulators can simulate and optimize complex multi-component systems, accelerating performance tuning, improving sustain...

Disruptive AI models are increasingly challenging traditional assumptions about “classic” cloud data centers. As training clusters scale up to thousands of accelerators and consume tens of megawatts of power, the conventional CPU-centric, air-cooled, monolithic server model is no longer sustainable. This research study explores the megatrend of AI ...

CDMOs are third-party vendors that offer outsourced development and manufacturing services for pharmaceutical drugs. In the small molecule manufacturing sector, CDMOs provide expert development and manufacturing services and are now an essential part of the pharmaceutical industry's value chain. The growing incidence of chronic diseases propels t...

Generative AI (Gen AI) continues to create an impact across industries including automotive. In the next decade, Gen AI is expected to significantly influence automotive value chains, increase efficiency, productivity, and reduce wastes. In the supply chain, it will be used to optimize inventory and demand forecasting while in product development i...

The impact of the digital revolution continues to disrupt the healthcare industry. This includes evolving digital technological capabilities, new business models and marketing approaches, the healthcare consumerism trend, the changing regulatory environment, and competitive threats from new market entrants, such as digital-native companies—particul...

In an evolving digital landscape, artificial intelligence (AI) is emerging as a preeminent force poised to reshape traditional job functions, operational processes, and business models. Cross-industry enterprises embrace innovative multimodal AI tools, solutions, and platforms to augment business growth, optimize operations, create strategic differ...

As global clinical pipelines witness a surge in complex novel therapies, there is a general inclination toward improving trial design through adaptive trial designs with technology-enabled solutions for planning and execution. Artificial intelligence (AI) is gaining large-scale recognition in terms of supporting decentralized trial designs and allo...